@inproceedings{inproceedings, title = {{Dupilumab Efficacy and Safety up to 2 Years in Children Aged 6 Months to 5 Years With Moderate-to-Severe Atopic Dermatitis}}, url = {{}}, year = {{2024}}, month = {{1}}, author = {{Su JC and Paller AS and Simpson EL and Siegfried EC and Cork MJ and Arkwright PD and Pinter A and Dubost-Brama A and Chen Z and Bansal A and Prescilla R et al}}, volume = {{34}}, journal = {{CRITICAL PUBLIC HEALTH}}, issue = {{1}}, pages = {{14-15}}, note = {{Accessed on 2025/05/28}}}